GENE ONLINE|News &
Opinion
Blog

Cell and Gene Therapy
Global Biotech Elites Gather to Explore Trends and Prospects of Cell and Gene Therapies
2023-08-09
2023 ASGCT Annual Meeting: Showcase of Exciting New Research, with a Focus on Clinical Applications
2023-06-02
Current Trends of iPSC Manufacturing and Clinical Applications – An Interview with Professor Xianmin Zeng
2023-03-29
Exciting Cell & Gene Therapy Research Updates in Glaucoma and Nerve Regeneration
2023-03-08
Developments in Regenerative Medicine: Gene Delivery Tools and Cell Therapy for Parkinson’s Disease
2023-03-08
Revolutionizing Eye Disease Treatment with iPSC Therapy
2023-03-07
Cell Therapy as a Pillar of Future Therapeutics, an Interview with Alex Huang, Vice President and Head of Cell Therapy at BeiGene
2022-10-05
Big Pharma-Backed Capstan Launches With $165 Million To Combine Cell Therapy And mRNA Technology
2022-09-15
These Pharma Companies Are Laying Off Employees Due to Restructuring
2022-06-30
BioMarin Wins First Gene Therapy Recommendation For Hemophilia A in Europe
2022-06-27
Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology
2022-05-27
Convergence, Communication and Commercialization, The Cornerstones In Emerging Regulatory Trends
2022-05-24
What If Our Body’s Power Station Goes Wrong? Gene Therapy May Help
2022-02-15
ARM 2022: Industry Briefs on Cell and Gene Therapies
2022-01-17
JPM
JPM22 Highlights: Cell and Gene Therapies Rise Up
2022-01-11
1 2 3 4 6
LATEST
One in Four U.S. Adults Turns to AI Tools for Health Care Advice
2026-04-15
Policy, Pricing, and Power: Why Europe’s Biotech Future Depends on Openness, Not Overregulation
2026-04-14
Vitiligo: Causes, Life-Changing Impacts, Treatment Challenges, and Breakthrough New Drugs
2026-04-14
Chris Chen Presents Faraday Future AI Robotics Advancements at Harvard Science Center
2026-04-14
General Lance W. Lord to Receive Space Foundation Lifetime Space Achievement Award for Leadership in Military Space Operations
2026-04-14
Ronald Kopas Reports 11.2 Percent Ownership in Delta Resources Following Private Share Acquisition
2026-04-14
Alcoa Corporation to Redeem $219 Million of 6.125% Notes Due 2028
2026-04-14
Scroll to Top